Hannah S. Bender

Hannah S. Bender

Auto-generated profile, based on publicly available information

Hannah S. Bender

Australian Registry of Wildlife Health, Taronga Conservation Society Australia, Mosman, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Science
Verified
Journal Article
Closed access
PDF file
EMElizabeth P. Murchison
Elizabeth P. Murchison
CTCesar Tovar
Cesar Tovar
AHArthur Hsu
Arthur Hsu
HBHannah S. Bender
Hannah S. Bender
PKPouya Kheradpour
Pouya Kheradpour
APAnthony T. Papenfuss
Anthony T. Papenfuss
Be-Deviled Cancer: Recently, a deadly transmissible cancer has emerged in Tasmanian devils, the largest existing marsupial carnivore. This disease, devil facial tumor disease (DFTD), leads to the growth of large facial tumors that frequently metastasize to internal organs. DFTD is thought to be transmitted by biting, and leads to death of affected animals within months, usually by obstructing the animals' ability to feed. Consequently, in the last 10 years Tasmanian devil numbers have dropped by about 60%. There are no genetic tests, vaccines, or treatments available for this disease, and without intervention, models predict that DFTD could cause extinction of Tasmanian devils in the wild within 50 years. Several lines of evidence suggest that DFTD is transmitted as a clonal allograft, whereby the cancer cells themselves are the agents of tumor transmission. Murchison et al. (p. 84 ) examined this hypothesis in detail by genotyping 25 tumor-host pairs from around Tasmania at 14 microsatellite loci and at a variable mitochondrial polymorphism. DFTD tumors were indeed found to be genetically distinct from their hosts and almost completely genetically identical to one another, supporting the idea of transmission by allograft.

1 April 2008 in Veterinary Microbiology
Verified
Journal Article
Closed access
SJS. Janeczko
S. Janeczko
DAD. Atwater
D. Atwater
EBE. Bogel
E. Bogel
AGA. Greiter-Wilke
A. Greiter-Wilke
AGA. Gerold
A. Gerold
KSK.W. Simpson
K.W. Simpson

16 February 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
Janine DeakinJanine Deakin
Janine Deakin
HBHannah S. Bender
Hannah S. Bender
APAnne-Maree Pearse
Anne-Maree Pearse
WRWillem Rens
Willem Rens
POPatricia C. M. O'BRien
Patricia C. M. O'BRien
JGJennifer Graves
Jennifer Graves
Devil facial tumour disease (DFTD) is a fatal, transmissible malignancy that threatens the world's largest marsupial carnivore, the Tasmanian devil, with extinction. First recognised in 1996, DFTD has had a catastrophic effect on wild devil numbers, and intense research efforts to understand and contain the disease have since demonstrated that the tumour is a clonal cell line transmitted by allograft. We used chromosome painting and gene mapping to deconstruct the DFTD karyotype and determine the chromosome and gene rearrangements involved in carcinogenesis. Chromosome painting on three different DFTD tumour strains determined the origins of marker chromosomes and provided a general overview of the rearrangement in DFTD karyotypes. Mapping of 105 BAC clones by fluorescence in situ hybridisation provided a finer level of resolution of genome rearrangements in DFTD strains. Our findings demonstrate that only limited regions of the genome, mainly chromosomes 1 and X, are rearranged in DFTD. Regions rearranged in DFTD are also highly rearranged between different marsupials. Differences between strains are limited, reflecting the unusually stable nature of DFTD. Finally, our detailed maps of both the devil and tumour karyotypes provide a physical framework for future genomic investigations into DFTD. The world's largest carnivorous marsupial, the Tasmanian devil, is threatened with extinction due to the emergence of devil facial tumour disease (DFTD), a fatal transmissible tumour. Critical loss of genetic diversity has rendered the devil vulnerable to transmission of tumour cells by grafting or transplanting the cells while biting and jaw wrestling. Initial studies of DFTD tumours revealed rearrangements among tumour chromosomes, with several missing chromosomes and four additional marker chromosomes of unknown origin. Since then, new strains of the disease have emerged and appear to be derived from the original strain. With no prior information available regarding the location of genes on normal devil chromosomes, a necessary first step towards characterisation of chromosome rearrangements in DFTD was to construct a map of the normal devil genome. This enabled us to elucidate the chromosome rearrangements in three DFTD strains. In doing so we determined the origin of the marker chromosomes and compared the three strains to determine which areas of the genome are involved in ongoing tumour evolution. Interestingly, rearrangements between strains are limited to particular genomic regions, demonstrating the unusual stability of this unique cancer. This study is therefore an important first step towards understanding the genetics of DFTD.

26 May 2023 in Science Advances
Verified
Journal Article
Closed access
HMHsiao-Yen Ma
Hsiao-Yen Ma
QLQingling Li
Qingling Li
WWWeng Ruh Wong
Weng Ruh Wong
ENElsa-Noah N’diaye
Elsa-Noah N’diaye
PCPatrick Caplazi
Patrick Caplazi
NDNing Ding
Ning Ding
Idiopathic pulmonary fibrosis is a progressive fibrotic disease characterized by excessive deposition of (myo)fibroblast produced collagen fibrils in alveolar areas of the lung. Lysyl oxidases (LOXs) have been proposed to be the central enzymes that catalyze the cross-linking of collagen fibers. Here, we report that, while its expression is increased in fibrotic lungs, genetic ablation of LOXL2 only leads to a modest reduction of pathological collagen cross-linking but not fibrosis in the lung. On the other hand, loss of another LOX family member, LOXL4, markedly disrupts pathological collagen cross-linking and fibrosis in the lung. Furthermore, knockout of both Loxl2 and Loxl4 does not offer any additive antifibrotic effects when compared to Loxl4 deletion only, as LOXL4 deficiency decreases the expression of other LOX family members including Loxl2 . On the basis of these results, we propose that LOXL4 is the main LOX activity underlying pathological collagen cross-linking and lung fibrosis.

25 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HBHannah S Bender
Hannah S Bender
EMElizabeth P Murchison
Elizabeth P Murchison
HPHilda A Pickett
Hilda A Pickett
Janine DeakinJanine Deakin
Janine Deakin
MSMargaret A Strong
Margaret A Strong
JGJennifer Graves
Jennifer Graves
Telomeres, specialised structures that protect chromosome ends, play a critical role in preserving chromosome integrity. Telomere dynamics in the Tasmanian devil (Sarcophilus harrisii) are of particular interest in light of the emergence of devil facial tumour disease (DFTD), a transmissible malignancy that causes rapid mortality and threatens the species with extinction. We used fluorescent in situ hybridisation to investigate telomere length in DFTD cells, in healthy Tasmanian devils and in four closely related marsupial species. Here we report that animals in the Order Dasyuromorphia have chromosomes characterised by striking telomere length dimorphism between homologues. Findings in sex chromosomes suggest that telomere length dimorphism may be regulated by events in the parental germlines. Long telomeres on the Y chromosome imply that telomere lengthening occurs during spermatogenesis, whereas telomere diminution occurs during oogenesis. Although found in several somatic cell tissue types, telomere length dimorphism was not found in DFTD cancer cells, which are characterised by uniformly short telomeres. This is, to our knowledge, the first report of naturally occurring telomere length dimorphism in any species and suggests a novel strategy of telomere length control. Comparative studies in five distantly related marsupials and a monotreme indicate that telomere dimorphism evolved at least 50 million years ago.

1 February 2014 in Annual Review of Animal Biosciences
Verified
Journal Article
Closed access
HBHannah S. Bender
Hannah S. Bender
JGJennifer Graves
Jennifer Graves
Janine DeakinJanine Deakin
Janine Deakin
The emergence of a fatal transmissible cancer known as devil facial tumor disease (DFTD) is threatening the iconic Tasmanian devil with extinction in the wild within the next few decades. Since the first report of the disease in 1996, DFTD has spread to over 85% of the devils’ distribution and dramatically reduced devil numbers. Research into DFTD has focused on gaining a deeper understanding of the disease on multiple levels, including an accurate assessment of the tissue origin of the tumor, elucidation of how the tumor evades immune detection, and determination of how the tumor is transmitted between individuals and how it is evolving as it spreads through the population. Knowledge gained from these studies has important implications for DFTD management and devil conservation.